Pregnancy-Associated Extracorporeal Membrane Oxygenation in the United States.

ABSTRACT:

Objective

The use of extracorporeal membrane oxygenation (ECMO) therapy has increased in the adult population. Studies from the H1N1 influenza pandemic suggest that ECMO deployment in pregnancy is associated with favorable outcomes. With increasing numbers of pregnant women affected by COVID-19 (coronavirus disease 2019) and potentially requiring this life-saving therapy, we sought to compare comorbidities, costs, and outcomes between pregnancy- and nonpregnancy-associated ECMO therapy among reproductive-aged female patients.

Study design

We used the 2013 to 2019 National Readmissions Database. Diagnosis and procedural coding were used to identify ECMO deployment, potential indications, comorbid conditions, and pregnancy outcomes. The primary outcome was in-hospital mortalit

SUBMITTER: Varvoutis MS 

PROVIDER: S-EPMC10425568 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature